×
About 30,506 results

ALLMedicine™ Menopause Center

Research & Reviews  12,527 results

Postmenopausal Hormone Therapy-Local and Systemic: A Pharmacologic Perspective.
https://doi.org/10.1002/jcph.1740
Journal of Clinical Pharmacology References; Smith T, Sahni S et. al.

Dec 4th, 2020 - Every woman, if she lives long enough, will transition into menopause, and as the US population ages, women will be spending more time in a postmenopausal state than before. For postmenopausal women, the decision to initiate menopausal hormone the...

HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Acr...
https://doi.org/10.1161/ATVBAHA.120.315355
Arteriosclerosis, Thrombosis, and Vascular Biology; El Khoudary SR, Chen X et. al.

Dec 3rd, 2020 - The cardioprotective capacity of HDL (high-density lipoprotein) cholesterol postmenopause has been challenged. HDL subclasses, lipid contents, and function might be better predictors of cardiovascular risk than HDL cholesterol. Changes in these me...

Assessing the safety of using the dry extract of Justicia pectoralis Jacq. (Acanthaceae...
https://doi.org/10.1016/j.jep.2020.113618
Journal of Ethnopharmacology; Carvalho M, Batista Caixeta GA et. al.

Dec 3rd, 2020 - Justicia pectoralis Jacq. (Acanthaceae), popularly known as tilo, chambá and anador, is widely used in folk medicine in Latin American countries as a sedative, anti-anxiety, reducing menopause symptoms and in the treatment of pathologies of the re...

Management of perimenopause disorders: hormonal treatment.
https://doi.org/10.1080/09513590.2020.1852544
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology; Troìa L, Martone S et. al.

Dec 2nd, 2020 - Perimenopause represents a transition period of a woman's life during which physiological, affective, psychological, and social changes mark progression from a woman's fertile life to menopause, with wide sexual hormones fluctuations until the ons...

Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early ...
https://doi.org/10.1161/CIR.0000000000000912
Circulation El Khoudary SR, Aggarwal B et. al.

Nov 30th, 2020 - Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable increase in the risk for this disease after menopause and typically develop coronary heart disease several years later than men. This observation led to the hy...

see more →

Guidelines  159 results

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557711/
Cureus Shah L

Oct 11th, 2020 - Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. Rheumatoid arthritis mainly consists of distal symmetrical deforming polyarthritis. SLE patients have immune compl...

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 5th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Radiofrequency-Based Devices for Female Genito-Urinary Indications: Position Statements...
https://doi.org/10.1016/j.jsxm.2019.12.015
The Journal of Sexual Medicine; Romero-Otero J, Lauterbach R et. al.

Mar 4th, 2020 - Radiofrequency (RF)-based treatment has been introduced as an esthetic alternative treatment for various medical indications without the scientific backup of a satisfactory body of evidence. Furthermore, the United States Food and Drug Administrat...

Reproductive and hormonal considerations in women at increased risk for hereditary gyne...
https://doi.org/10.1016/j.fertnstert.2019.07.1349
Fertility and Sterility; Chen LM, Blank SV et. al.

Oct 13th, 2019 - Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions on reproductive and hormonal health. This document reviews potential options for cancer prevention, family building, genetic testi...

see more →

Drugs  431 results see all →

Clinicaltrials.gov  14,889 results

Postmenopausal Hormone Therapy-Local and Systemic: A Pharmacologic Perspective.
https://doi.org/10.1002/jcph.1740
Journal of Clinical Pharmacology References; Smith T, Sahni S et. al.

Dec 4th, 2020 - Every woman, if she lives long enough, will transition into menopause, and as the US population ages, women will be spending more time in a postmenopausal state than before. For postmenopausal women, the decision to initiate menopausal hormone the...

HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Acr...
https://doi.org/10.1161/ATVBAHA.120.315355
Arteriosclerosis, Thrombosis, and Vascular Biology; El Khoudary SR, Chen X et. al.

Dec 3rd, 2020 - The cardioprotective capacity of HDL (high-density lipoprotein) cholesterol postmenopause has been challenged. HDL subclasses, lipid contents, and function might be better predictors of cardiovascular risk than HDL cholesterol. Changes in these me...

Assessing the safety of using the dry extract of Justicia pectoralis Jacq. (Acanthaceae...
https://doi.org/10.1016/j.jep.2020.113618
Journal of Ethnopharmacology; Carvalho M, Batista Caixeta GA et. al.

Dec 3rd, 2020 - Justicia pectoralis Jacq. (Acanthaceae), popularly known as tilo, chambá and anador, is widely used in folk medicine in Latin American countries as a sedative, anti-anxiety, reducing menopause symptoms and in the treatment of pathologies of the re...

Management of perimenopause disorders: hormonal treatment.
https://doi.org/10.1080/09513590.2020.1852544
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology; Troìa L, Martone S et. al.

Dec 2nd, 2020 - Perimenopause represents a transition period of a woman's life during which physiological, affective, psychological, and social changes mark progression from a woman's fertile life to menopause, with wide sexual hormones fluctuations until the ons...

New AHA Scientific Statement on Menopause and CVD Risk
https://www.medscape.com/viewarticle/941848

Dec 1st, 2020 - Changes in hormones, body composition, lipids, and vascular health during the menopause transition can increase a woman's chance of developing cardiovascular disease (CVD) after menopause, the American Heart Association (AHA) said in a scientific ...

see more →

News  2,321 results

New AHA Scientific Statement on Menopause and CVD Risk
https://www.medscape.com/viewarticle/941848

Dec 1st, 2020 - Changes in hormones, body composition, lipids, and vascular health during the menopause transition can increase a woman's chance of developing cardiovascular disease (CVD) after menopause, the American Heart Association (AHA) said in a scientific ...

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Local Estrogen Therapy for Vaginal Atrophy Can Start Before or After Age 60
https://www.staging.medscape.com/viewarticle/939558

Oct 21st, 2020 - NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc analysis of a randomized, placebo-controlled trial in the US and Canad...

Local Estrogen Therapy for Vaginal Atrophy Can Start Before or After Age 60
https://www.medscape.com/viewarticle/939558

Oct 21st, 2020 - NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc analysis of a randomized, placebo-controlled trial in the US and Canad...

More Women Trying Cannabis to Manage Menopause Symptoms
https://www.staging.medscape.com/viewarticle/939410

Oct 19th, 2020 - A new study finds 1 in 4 women have tried cannabis to manage menopause symptoms. Laura Hamilton is one of them. She's used pot recreationally since she was in college, but was surprised when she realized it was helping ease her menopause symptoms,...

see more →

Patient Education  179 results see all →